Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050655
Filing Date
2020-11-05
Accepted
2020-11-04 18:25:27
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gwph-10q_20200930.htm   iXBRL 10-Q 1918793
2 EX-10.1 gwph-ex101_12.htm EX-10.1 133269
3 EX-31.1 gwph-ex311_8.htm EX-31.1 16438
4 EX-31.2 gwph-ex312_7.htm EX-31.2 16473
5 EX-32.1 gwph-ex321_9.htm EX-32.1 6040
6 EX-32.2 gwph-ex322_6.htm EX-32.2 6132
7 GRAPHIC gq4g0bvdkfap000001.jpg GRAPHIC 4080
  Complete submission text file 0001564590-20-050655.txt   5368386

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA gwph-20200930.xsd EX-101.SCH 28357
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gwph-20200930_cal.xml EX-101.CAL 49309
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gwph-20200930_def.xml EX-101.DEF 61660
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20200930_lab.xml EX-101.LAB 242781
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20200930_pre.xml EX-101.PRE 168798
13 EXTRACTED XBRL INSTANCE DOCUMENT gwph-10q_20200930_htm.xml XML 772013
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35892 | Film No.: 201288047
SIC: 2834 Pharmaceutical Preparations